Dr Hatim Husain Discusses HER2, Novel Therapy Exploration in Lung Cancer
During the Quality Cancer Care Alliance Summer 2022 National Leadership Summit, Hatim Husain, MD, discusses how HER2 exploration in lung cancer differs from that in breast cancer, as well as novel therapies being explored for HER2 and other disease targets.
Dr Hatim Husain: NCCN Guidelines Adjust to Meet Lung Cancer Treatment Needs
Hatim Husain, MD, discusses how National Comprehensive Cancer Network (NCCN) treatment guidelines adjust to meet the treatment needs of patients with lung cancer.
Dr Hatim Husain: Biomarker Testing Is a Treatment Cornerstone in NSCLC
Hatim Husain, MD, associate professor in the Department of Medicine at UC San Diego, discuses must-haves for successful biomarker testing in lung cancer—in particular, non–small cell lung cancer (NSCLC)—and how the field is adapting to the targeted treatment needs of its patients.
QCCA Panel Highlights Expansion of Innovation at Independent Community Oncology
Value management, theranostics, clinical trial access, and a mobile pharmacy are major innovations being integrated into independent community oncology practices, as highlighted at the Quality Cancer Care Alliance Summer 2022 National Leadership Summit.
Dr John Frownfelter: The Future of Healthcare Is Prescriptive Analytics
Prescriptive analytics, not just predictive analytics, will make a difference in patient outcomes, said John Frownfelter, MD, FACP, chief medical officer of Jvion.
Mike Fazio: APM Uptake Requires Helping Providers Understand How to Protect Against Risk
The industry does not do a very good job of letting providers know there are ways to cover risk or protect against it. Better educating physicians on this would help improve uptake of value-based care models, said Mike Fazio, senior vice president of client services, Archway Health.
Dr John Frownfelter Discusses What Is Needed to Get Healthcare Comfortable With AI in Practice
Healthcare needs to learn to adapt faster to changes, said John Frownfelter, MD, FACP, chief medical officer of Jvion.
Mike Fazio Discusses How Practices Can Balance Participating in Multiple APMs
Depending on the type of alternative payment models, it could be more difficult or easier for practices to find overlaps and participate in multiple models, said Mike Fazio, senior vice president of client services, Archway Health.
Dr John Frownfelter on Collecting Health Data
More and more data are being collected on people and in healthcare, patients have to believe that the data being collected is for their good and with the goal of improving their care, said John Frownfelter, MD, FACP, chief medical officer of Jvion.
Mike Fazio Highlights Interest in Data and Benchmarking in OCM
Practices participating in the Oncology Care Model (OCM) have been interested in understanding the data and what it tells them about how to focus their efforts, said Mike Fazio, senior vice president of client services, Archway Health.
Dr John Frownfelter: AI Helps Derive Meaning From Collected Healthcare Data
Artificial intelligence (AI) can help derive meaning from data collected in healthcare to avoid noise and wasted efforts, said John Frownfelter, MD, FACP, chief medical officer of Jvion.
Kathy W. Oubre Outlines the Full Breadth of Financial Assistance Offered at Pontchartrain Cancer Center
As costs for cancer care continue to rise, Pontchartrain Cancer Center does benefit and cost analyses for all patients before they start therapy and also takes into account any social needs they might have, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center.
Mike Fazio Breaks Down the Decision to Take on Downside Risk in OCM
More practices than expected seem to be interested in staying in the Oncology Care Model (OCM) and taking on downside risk, said Mike Fazio, senior vice president of client services, Archway Health.
Dr John Frownfelter Discusses AI in Healthcare Practices
Artificial intelligence (AI) is now being used in healthcare practices to risk stratify patients and identify interventions that will work, said John Frownfelter, MD, FACP, chief medical officer of Jvion.
Susan Dentzer on Finding Room to Pay for Expensive, Life-Changing Therapies
To make headroom for expensive, potentially curative therapies in the pipeline, the healthcare needs to remove ineffective care from the system, said Susan Dentzer, visiting fellow at the Duke-Margolis Center for Health Policy.
Evolving Healthcare Beyond the Conventional Walls of the Delivery System
Healthcare does not necessarily need to be disrupted, but it does need to evolve and utilize technology so that cancer care can move beyond the conventional walls of the healthcare delivery system, said Susan Dentzer, visiting fellow at the Duke-Margolis Center for Health Policy, during her keynote speech at the Quality Cancer Care Alliance’s Leadership Summit.
Mike Fazio: Practices Are Happier With PP4 Results in the OCM
There are less surprises in the results for performance period 4 of the Oncology Care Model, and practices seem to be mostly happier with how they’ve done, said Mike Fazio, senior vice president of client services, Archway Health.
2 Clarke Drive Cranbury, NJ 08512